Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -7.22 is 64% below its 5-year average of -4.39, near the low end of its 5-year range (-7.22–-1.97).
22.37% below its 12-month average of -5.90.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -1.50.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T22:36:27.027Z. Historical observations retain their original dates. Historical series through 2017-05-04.
EARNINGS PER SHARE (EPS)
-7.22
EARNINGS PER SHARE (EPS) AVG TTM
-5.90
EARNINGS PER SHARE (EPS) AVG 3Y
-5.40
EARNINGS PER SHARE (EPS) AVG 5Y
-4.39
EARNINGS PER SHARE (EPS) AVG 10Y
-3.09
EARNINGS PER SHARE (EPS) AVG 15Y
-2.91
EARNINGS PER SHARE (EPS) AVG 20Y
-3.58
CURRENT VS TTM AVG
-22.37%
CURRENT VS 3Y AVG
-33.83%
CURRENT VS 5Y AVG
-64.40%
CURRENT VS 10Y AVG
-133.31%
CURRENT VS 15Y AVG
-148.38%
CURRENT VS 20Y AVG
-101.70%
Cytokinetics, Incorporated
Market Cap
$7.63B
Earnings Per Share (EPS)
-7.22
TTM Avg
-5.90
3Y Avg
-5.40
5Y Avg
-4.39
Market Cap
$7.61B
Earnings Per Share (EPS)
2.77
TTM Avg
1.81
3Y Avg
0.99
5Y Avg
0.59
Market Cap
$7.61B
Earnings Per Share (EPS)
1.29
TTM Avg
-2.76
3Y Avg
-2.30
5Y Avg
-2.30
Market Cap
$7.76B
Earnings Per Share (EPS)
0.36
TTM Avg
-1.91
3Y Avg
-1.77
5Y Avg
-0.94
Market Cap
$7.81B
Earnings Per Share (EPS)
-12.93
TTM Avg
-11.85
3Y Avg
-27.93
5Y Avg
-45.71
Market Cap
$7.31B
Earnings Per Share (EPS)
-3.46
TTM Avg
-2.71
3Y Avg
-2.47
5Y Avg
-2.21
Market Cap
$7.99B
Earnings Per Share (EPS)
2.74
TTM Avg
1.63
3Y Avg
0.47
5Y Avg
-0.53
Market Cap
$8.38B
Earnings Per Share (EPS)
1.40
TTM Avg
-0.79
3Y Avg
-1.41
5Y Avg
-1.76
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cytokinetics, Incorporated (CYTK) | $7.63B | -7.22 | -5.90 | -5.40 | -4.39 |
| HealthEquity, Inc. (HQY)vs › | $7.61B | 2.77 | 1.81 | 0.99 | 0.59 |
| Hinge Health, Inc. (HNGE)vs › | $7.61B | 1.29 | -2.76 | -2.30 | -2.30 |
| Caris Life Sciences, Inc. (CAI)vs › | $7.76B | 0.36 | -1.91 | -1.77 | -0.94 |
| Praxis Precision Medicines, Inc. (PRAX)vs › | $7.81B | -12.93 | -11.85 | -27.93 | -45.71 |
| Ionis Pharmaceuticals, Inc. (IONS)vs › | $7.31B | -3.46 | -2.71 | -2.47 | -2.21 |
| TG Therapeutics, Inc. (TGTX)vs › | $7.99B | 2.74 | 1.63 | 0.47 | -0.53 |
| Alkermes plc (ALKS)vs › | $6.99B | 0.38 | 1.85 | 1.22 | 0.64 |
| Oscar Health, Inc. (OSCR)vs › | $8.38B | 1.40 | -0.79 | -1.41 | -1.76 |
| Chemed Corporation (CHE)vs › | $6.66B | 19.92 | 19.26 | 18.34 | 18.42 |
Trailing EPS (TTM)
$-7.22
Forward EPS (Est.)
$-6.05
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -6.54 |
| 2024-12-31 | -5.26 |
| 2023-12-31 | -5.45 |
| 2022-12-31 | -4.33 |
| 2021-12-31 | -2.80 |
| 2020-12-31 | -1.97 |
| 2019-12-31 | -2.59 |
| 2018-12-31 | -1.95 |
| 2017-12-31 | -2.59 |
| 2016-12-31 | 0.41 |
| 2015-12-31 | -0.97 |
| 2014-12-31 | -0.41 |
| 2013-12-31 | -1.24 |
| 2012-12-31 | -2.15 |
| 2011-12-31 | -4.06 |
| 2010-12-31 | -4.61 |
| 2009-12-31 | 2.58 |
| 2008-12-31 | -6.85 |
| 2007-12-31 | -6.16 |
| 2006-12-31 | -9.36 |
| 2005-12-31 | -8.87 |
| 2004-12-31 | -11.28 |
| 2003-12-31 | -102.62 |
| 2002-12-31 | -79.49 |
| 2001-12-31 | -67.08 |
| 2000-12-31 | -81.30 |
